http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : Liao Sheng-Feng (검색결과 4 건)
- 무료
- 기관 내 무료
- 유료
-
Study on the Patterns of Library Resource Construction and Services in MOOC
Sun Ji-zhou,Liao Sheng-feng 보안공학연구지원센터 2014 International Journal of u- and e- Service, Scienc Vol.7 No.6
It is of great significance to reform the patterns of library resource construction and services in MOOC, for example, it can help to fulfill the individual needs of learners, and achieve sustainable development for the library. Firstly, the author analyzes the characteristics of MOOC; secondly, discusses the characteristics of information construction of library; and then designs a knowledge discovery model of the library information resources construction in MOOC; finally proves that it could provide favorable support for the improvement of library resource construction and services to discover knowledge from library data base according to the result of case study.
-
Phase II trial of VEGFR2 inhibitor apatinib for metastatic sarcoma: focus on efficacy and safety
Zhichao Liao,Feng Li,Chao Zhang,Lei Zhu,Yehui Shi,Gang Zhao,Xu Bai,Shafat Hassan,Xinyue Liu,Ting Li,Peipei Xing,Jun Zhao,Jin Zhang,Ruwei Xing,Sheng Teng,Yun Yang,Kexin Chen,Jilong Yang 생화학분자생물학회 2019 Experimental and molecular medicine Vol.51 No.-
Apatinib (YN968D1) is a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor 2 (VEGFR- 2). We conducted a single-arm, nonrandomized phase II study (NCT03121846) to assess the efficacy and safety of apatinib in patients with stage IV sarcoma. We recruited 64 patients with stage IV sarcoma who had failed chemotherapy. The primary endpoint was progression-free survival (PFS), and the secondary endpoints were progression-free survival rate (PFR), objective response rate (ORR), and disease control rate (DCR) at week 12. Treatment-related adverse effects (AEs) were evaluated. Fifty-nine patients were assessed for efficacy and 64 patients for AEs. The median PFS was 7.93 months. At 12 weeks, the PFR was 74%, the ORR was 16.95% (10/59), and the DCR was 86.44% (51/59). The final ORR was 15.25% (9/59) and the DCR was 57.63% (34/59). Notably, 22 patients (34.38%) who developed hypertension, hand-foot-skin reaction, or proteinuria had significantly longer OS than those without these AEs (18.20 vs. 10.73 months; P = 0.002). We conclude that apatinib is effective and well tolerated in patients with advanced sarcoma. The development of hypertension, hand-foot-skin reaction, or proteinuria may indicate a favorable prognosis, representing a novel finding in sarcoma patients.
-
Study on the Patterns of Library Resource Construction and Services in MOOC
Sun Ji-Zhou,Liao Sheng-Feng 보안공학연구지원센터 2015 International Journal of Hybrid Information Techno Vol.8 No.5
It is of great significance to reform the patterns of library resource construction and services in MOOC, for example, it can help to fulfill the individual needs of learners, and achieve sustainable development for the library. Firstly, the author analyzes the characteristics of MOOC; secondly, discusses the characteristics of information construction of library; and then designs a knowledge discovery model of the library information resources construction in MOOC; finally proves that it could provide favorable support for the improvement of library resource construction and services to discover knowledge from library data base according to the result of case study.
-
Traditional medicine for post-viral olfactory dysfunction: A systematic review
Zou, Xiang-yun,Liu, Xue-han,Lu, Chun-li,Jin, Xin-yan,He, Bai-xiang,Liao, Yi-lei,Liu, Ting,Dai, Yi-dan,Qi, Shi-hao,Sheng, Zhu-jun,Yan, Zhan-feng,Yang, Guo-Yan,Stub, Trine,Liu Jian-Ping 한국한의학연구원 2024 Integrative Medicine Research Vol.13 No.2
Background: Post-viral olfactory dysfunction (PVOD) is the common symptoms of long COVID, lacking of effective treatments. Traditional Chinese medicine (TCM) is claimed to be effective in treating olfactory dysfunction, but the evidence has not yet been critically appraised. We conducted a systematic review to evaluate the effectiveness and safety of TCM for PVOD. Methods: We searched eight databases to identified clinical controlled studies about TCM for PVOD. The Cochrane risk of bias tools and GRADE were used to evaluate the quality of evidence. Risk ratio (RR), mean differences (MD), and 95 % confidence interval (CI), were used for effect estimation and RevMan 5.4.1 was used for data analysis. Results: Six randomized controlled trials (RCTs) (545 participants), two non-randomized controlled trials (non-RCTs) (112 participants), and one retrospective cohort study (30 participants) were included. The overall quality of included studies was low. Acupuncture (n = 8) and acupoint injection (n = 3) were the mainly used TCM therapies. Five RCTs showed a better effect in TCM group. Four trials used acupuncture, and three trials used acupoint injection. The results of two non-RCTs and one cohort study were not statistically significant. Two trials reported mild to moderate adverse events (pain and brief syncope caused by acupuncture or acupoint injection). Conclusions: Limited evidence focus on acupuncture and acupoint injection for PVOD and suggests that acupuncture and acupoint injection may be effective in improving PVOD. More well-designed trials should focus on acupuncture to confirm the benefit. Protocol registration: The protocol of this review was registered at PROSPERO: CRD42022366776.
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
